Silence Therapeutics plc (SLN) stock
SLNNasdaqPharmaceutical PreparationsAlso trades as SLNCF
$19.80+0.00 (0.00%)
Close on Nov 17, 2026Market cap $935.48MP/E –Yield –
Silence Therapeutics total assets
Total assets on the balance sheet at the end of each period.
Silence Therapeutics's total assets was $281.50M at Sep 30, 2026. For fiscal 2025 it was $131.44M, down 35.1% from the year before.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $131.44M | -35.1% |
| FY2024 | Dec 31, 2024 | $202.64M | +69.6% |
| FY2023 | Dec 31, 2023 | $119.45M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $281.50M | +91.8% |
| Q2 FY2026 | Jun 30, 2026 | $106.41M | -35.6% |
| Q1 FY2026 | Mar 31, 2026 | $115.12M | -37.9% |
| Q4 FY2025 | Dec 31, 2025 | $131.44M | -35.1% |
| Q3 FY2025 | Sep 30, 2025 | $146.79M | +22.9% |
| Q2 FY2025 | Jun 30, 2025 | $165.23M | – |
| Q1 FY2025 | Mar 31, 2025 | $185.30M | – |
| Q4 FY2024 | Dec 31, 2024 | $202.64M | – |
| Q4 FY2023 | Dec 31, 2023 | $119.45M | – |
See a number that looks wrong?